Pulmonary veno-occlusive disease in myeloproliferative disorder

Willems E., Canivet J-L., Ghaye B., de Leval L., Radermecker M., Preiser J-C., Beguin Y.

Source: Eur Respir J 2009; 33: 213-216
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Willems E., Canivet J-L., Ghaye B., de Leval L., Radermecker M., Preiser J-C., Beguin Y.. Pulmonary veno-occlusive disease in myeloproliferative disorder. Eur Respir J 2009; 33: 213-216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir J 2010; 35: 1396-1406
Year: 2010



Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir Rev 2015; 24: 400-410
Year: 2015



Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Prevalance of pulmonary hypertension in chronic myeloproliferative diseases
Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Year: 2011


Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Source: Eur Respir J 2009; 33: 1498-1502
Year: 2009



Pulmonary disorders in chronic renal failure
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005

Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture
Source: Eur Respir J 2009; 33: 666-669
Year: 2009



Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Pulmonary veno-occlusive disease
Source: Eur Respir J 2016; 47:1518-1534
Year: 2016



Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis
Source: Eur Respir Rev 2009; 18: 125-128
Year: 2009